Neurocrine Nears $2.5B Deal for Soleno Neurocrine reportedly close to buying Soleno for $2.5B+ (FT, Apr 6, 2026); deal structure and milestone split will determine ultimate value and timing.

Neurocrine Nears $2.5B Deal for Soleno: Neurocrine reportedly close to buying Soleno for $2.5B+ (FT, Apr 6, 2026); deal structure and milestone split will determine ultimate value and timing. 👈 Read full analysis #Neurocrine #Soleno #BusinessNews #MergersAndAcquisitions #HealthcareInvesting

Neurocrine Nears $2.5bn Deal for Soleno Neurocrine is reportedly in talks to buy Soleno for >$2.5bn (FT Apr 6, 2026). Soleno sells the first commercial therapy for hyperphagia in Prader-Willi syndrome.

Neurocrine Nears $2.5bn Deal for Soleno: Neurocrine is reportedly in talks to buy Soleno for >$2.5bn (FT Apr 6, 2026). Soleno sells the first commercial therapy for hyperphagia in Prader-Willi syndrome. 👈 Read full analysis #Neurocrine #Soleno #Pharmaceuticals #Acquisition #Healthcare